Patents by Inventor Pranav Parmjit Singh

Pranav Parmjit Singh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230057154
    Abstract: Systems and methods for identifying variant alleles as somatic or germline are provided. Reference and variant alleles for a genomic position are identified. Methylation states and sequences of nucleic acid fragment sequences that map to the genomic position are obtained from a sample of a subject. Using the sequences of nucleic acid fragment sequences, each nucleic acid fragment sequence that has the reference allele is assigned to a reference subset, and each nucleic acid fragment sequence that has the variant allele is assigned to a variant subset. One or more indications of the methylation states across the nucleic acid fragment sequences in the variant subset and an indication of the number of nucleic acid fragment sequences in the reference subset versus the variant subset are applied to a trained binary classifier. An identification of the variant allele at the genomic position as somatic or germline is obtained from the classifier.
    Type: Application
    Filed: August 4, 2022
    Publication date: February 23, 2023
    Applicant: GRAIL, LLC
    Inventors: Pranav Parmjit Singh, Oliver Claude Venn
  • Publication number: 20230002824
    Abstract: Cell free nucleic acids from a test sample obtained from an individual are analyzed to identify possible fusion events. Cell free nucleic acids are sequenced and processed to generate fragments. Fragments are decomposed into kmers and the kmers are either analyzed de novo or compared to targeted nucleic acid sequences that are known to be associated with fusion gene pairs of interest. Thus, kmers that may have originated from a fusion event can be identified. These kmers are consolidated to generate gene ranges from various genes that match sequences in the fragment. A candidate fusion event can be called given the spanning of one or more gene ranges across the fragment.
    Type: Application
    Filed: September 1, 2022
    Publication date: January 5, 2023
    Inventors: Xiao Yang, Hyunsung John Kim, Wenying Pan, Matthew H. Larson, Eric Michael Scott, Pranav Parmjit Singh, Mohini Jangi Desai
  • Patent number: 11473137
    Abstract: Cell free nucleic acids from a test sample obtained from an individual are analyzed to identify possible fusion events. Cell free nucleic acids are sequenced and processed to generate fragments. Fragments are decomposed into kmers and the kmers are either analyzed de novo or compared to targeted nucleic acid sequences that are known to be associated with fusion gene pairs of interest. Thus, kmers that may have originated from a fusion event can be identified. These kmers are consolidated to generate gene ranges from various genes that match sequences in the fragment. A candidate fusion event can be called given the spanning of one or more gene ranges across the fragment.
    Type: Grant
    Filed: June 12, 2018
    Date of Patent: October 18, 2022
    Assignee: GRAIL, LLC
    Inventors: Xiao Yang, Hyunsung John Kim, Wenying Pan, Matthew H. Larson, Eric Michael Scott, Pranav Parmjit Singh, Mohini Jangi Desai
  • Publication number: 20220093211
    Abstract: Detecting cross-contamination between test samples used for determining cancer in a subject is beneficial. To detect cross-contamination, test sequences including at least one single nucleotide polymorphism are prepared using genome sequencing techniques. Some of the test sequences can be filtered to improve accuracy and precision. A prior contamination probability for each test sequence is determined based on a minor allele frequency. A contamination model including a likelihood test is applied to a test sequence. The likelihood test obtains a current contamination probability representing the likelihood that the test sample is contaminated. The contamination model can also determine a likelihood that the sample includes loss of heterozygosity representing the likelihood that the test sequence is contaminated. Test samples that are contaminated are removed. A source for the contaminated test sample can be found by comparing contaminated test sequences to other test sequences.
    Type: Application
    Filed: September 17, 2021
    Publication date: March 24, 2022
    Inventors: ONUR SAKARYA, CHRISTOPHER-JAMES A.V. YAKYM, PRANAV PARMJIT SINGH, ROBERT ABE PAINE CALEF, RICHARD HUANG
  • Publication number: 20200340064
    Abstract: Systems and methods for cancer subject tumor fraction estimation comprise obtaining a first plurality of nucleic acid fragment sequences from the subject's liquid biological sample. The first plurality of sequences represent cell-free nucleic acids in the liquid sample. A second plurality of nucleic acid fragment sequences is obtained from the subject's tumor sample. The second plurality of sequences represent nucleic acid molecules in the tumor. Smoothed noise rates, each determined using nucleic acid fragment sequences from non-cancer samples mapping to a corresponding allele position in a plurality of allele positions, are obtained. Variant allele counts and coverages are determined for the allele positions using the first plurality of sequences. Solid variant allele fractions are determined for the plurality of allele positions using the second plurality of sequences.
    Type: Application
    Filed: April 16, 2020
    Publication date: October 29, 2020
    Inventors: Samuel S. Gross, Joshua Newman, Pranav Parmjit Singh, Collin Melton, Oliver Claude Venn, Earl Hubbell
  • Publication number: 20180355423
    Abstract: Cell free nucleic acids from a test sample obtained from an individual are analyzed to identify possible fusion events. Cell free nucleic acids are sequenced and processed to generate fragments. Fragments are decomposed into kmers and the kmers are either analyzed de novo or compared to targeted nucleic acid sequences that are known to be associated with fusion gene pairs of interest. Thus, kmers that may have originated from a fusion event can be identified. These kmers are consolidated to generate gene ranges from various genes that match sequences in the fragment. A candidate fusion event can be called given the spanning of one or more gene ranges across the fragment.
    Type: Application
    Filed: June 12, 2018
    Publication date: December 13, 2018
    Inventors: Xiao Yang, Hyungsung John Kim, Wenying Pan, Matthew H. Larson, Eric Michael Scott, Pranav Parmjit Singh, Mohini Jangi Desai